Hitomi Hosoya

Also affiliated with Stanford Blood Center, Stanford University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Antibody-Based Treatment Approaches in Multiple Myeloma”.

Antibody-Based Treatment Approaches in Multiple Myeloma

Current Hematologic Malignancy Reports(2021)10.1007/s11899-021-00624-6

N/A

0.727DataRank · unranked

12 citations

Surbhi Sidana, Hitomi Hosoya

Phase 2 study of MGTA-145 + plerixafor for rapid and reliable hematopoietic stem cell (HSC) mobilization for autologous transplant in multiple myeloma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8023

N/A

0DataRank · unranked

1 citations

Andriyana K. Bankova, Hitomi Hosoya, Lori Muffly, Shaji Kumar, Laura Johnston +14 more

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Blood(2024)10.1182/blood.2024025945

N/A

0DataRank · unranked

130 citations

Krina K. Patel, Lauren C. Peres, Radhika Bansal, Mehmet H. Kocoglu, Leyla Shune +33 more